Home Your basket
• Voice rehabilitation afte...
   Price 10.50 €
• Liposarcoma of the hypoph...
   Price 5.50 €
• Retrosigmoid vestibular n...
   Price 5.50 €
• The Bell Labs contributio...
   Price 12.50 €
• Laryngeal paraganglioma m...
   Price 8.50 €
• Total pharyngolayngectomy...
   Price 10.50 €
• Post operative Caldwell-L...
   Price 10.00 €
• Art and nose....
   Price 8.50 €
• Dynamic palatography: Dia...
   Price 12.50 €
• Aesthetic parotidectomy: ...
   Price 8.50 €
• Prosodic analysis of spee...
   Price 10.50 €
• Validation of a self asse...
   Price 10.50 €
• Unusual location of pleom...
   Price 12.50 €
• Decompression surgery for...
   Price 8.50 €
• Voice Handicap Index adap...
   Price 10.50 €
• Asymptomatic findings on ...
   Price 14.00 €
• "Endolymphatic" cochleo-v...
   Price 10.50 €
• Prevalence of sensineural...
   Price 14.00 €
• Context influence on the ...
   Price 10.50 €
• The symphonix symposium u...
   Price 8.50 €
• Evaluation of the use of ...
   Price 8.50 €
• Technique of upper blepha...
   Price 10.50 €
• Evaluation and treatment ...
   Price 8.50 €
• A report of two cases of ...
   Price 5.50 €
• Functional septal surgery...
   Price 10.50 €
• Importance of a molding n...
   Price 10.50 €
• Interventional phoniatry...
   Price 14.00 €
• A new case of rhinosclero...
   Price 5.50 €
• Mycobacterial cervical ly...
   Price 10.50 €
• Mast cells in chronic inf...
   Price 10.50 €
• Bilateral cleft lip and c...
   Price 14.00 €
• The effect of the speaker...
   Price 10.50 €
• International Conference ...
   Price 5.50 €
• Facial nerve monitoring i...
   Price 10.50 €
• Vestibular neuritis: aeti...
   Price 8.50 €

Total Order 346.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2000 o

LARYNGOLOGY

Evaluation of the primary tumour and the metastatic lymph node with or without extracapsular spread by means of argyrophillic nucleolar regions (AgNOR)


Authors : C. Bilgen, S. Sarioglu, K. Ceryan (Izmir)

Ref. : Rev Laryngol Otol Rhinol. 2000;121,3:155-159.

Article published in english
Downloadable PDF document english



Summary : Though TNM staging is the most popular clinical system for defining the prognosis of Head and Neck Squamous Cell Carcinoma (HNSCC), different clinical trials of the tumours with the same TNM stage have caused doubts about this system. Extra Capsular Spread (ECS) in a metastatic lymph node is one of the recently defined prognostic factors in HNSCC. The hypothesis of this study was to assess the relationship between the primary tumour of laryngeal and oral cavity squamous cell carcinoma and the metastatic lymph nodes with and without ECS. The argyrophillic Nucleolar Organiser Regions (AgNOR) count was used as an index of the grade of malignancy of the neoplastic tissue. As a result, significantly higher AgNOR counts were obtained in the metastatic lymph nodes with ECS than in the primary tumours, while the lowest AgNOR counts were found in the metastatic lymph nodes without ECS. However, when primary tumours of the metastatic lymph nodes with ECS and the primary tumours of the metastatic lymph nodes without ECS were compared, no significant difference was found.

Price : 5.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE